Show simple item record

dc.contributor.authorWorld Health Assembly, 17
dc.coverage.spatialGenevaEN
dc.date.accessioned2014-10-15T17:23:30Z
dc.date.available2014-10-15T17:23:30Z
dc.date.issued1964
dc.identifier.govdocA17/P&B/19
dc.identifier.urihttps://iris.who.int/handle/10665/136510
dc.language.isoenEN
dc.publisherWorld Health OrganizationEN
dc.subjectResearchEN
dc.subjectPharmaceutical productsEN
dc.subject.meshResearchEN
dc.subject.meshHealth Services ResearchEN
dc.subject.meshWorld Health OrganizationEN
dc.subject.meshProgram DevelopmentEN
dc.subject.meshPharmaceutical PreparationsEN
dc.subject.meshDrug EvaluationEN
dc.subject.meshSubstance-Related DisordersEN
dc.titleDraft fourth report of the Committee on Programme and BudgetEN
dc.typeGoverning body documentsEN
dc.subject.meshqualifierorganization and administrationEN
dc.subject.meshqualifierstandardsEN


Files in this item

Thumbnail

This item appears in the following Collection(‎s)‎

Show simple item record